Imagion Biosystems Ltd. (AU:IBX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Imagion Biosystems Ltd. has secured $3 million in new funding through a share placement led by CPS Capital, which will accelerate the company’s MagSense technology clinical programs for cancer detection. Additionally, the company has entered into a licensing agreement with Biosensis to commercialize its PrecisionMRX nanoparticles, providing a new revenue stream through milestone fees and royalties. These strategic moves are expected to bolster Imagion’s market position and enhance its research and development efforts.
For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.